Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy.

Franco EL, de Sanjosé S, Broker TR, Stanley MA, Chevarie-Davis M, Isidean SD, Schiffman M.

Vaccine. 2012 Nov 20;30 Suppl 5:F175-82. doi: 10.1016/j.vaccine.2012.06.092. Review.

2.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Nov 22;31 Suppl 8:I1-31. doi: 10.1016/j.vaccine.2013.07.026. Review.

3.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001. Review.

PMID:
24331745
4.

Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.

Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA.

Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066. Review.

PMID:
24331747
5.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.

Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S.

Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029. Review.

PMID:
24332298
6.

Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.

Adefuye PO, Broutet NJ, de Sanjosé S, Denny LA.

Vaccine. 2013 Dec 29;31 Suppl 5:F53-9. doi: 10.1016/j.vaccine.2012.06.070. Review.

PMID:
24331748
7.

Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.

Steben M, Jeronimo J, Wittet S, Lamontagne DS, Ogilvie G, Jensen C, Smith J, Franceschi S.

Vaccine. 2012 Nov 20;30 Suppl 5:F183-91. doi: 10.1016/j.vaccine.2012.06.031. Review.

PMID:
23199962
8.

Burden of human papillomavirus infection and related diseases in Israel.

Shavit O, Roura E, Barchana M, Diaz M, Bornstein J.

Vaccine. 2013 Nov 22;31 Suppl 8:I32-41. doi: 10.1016/j.vaccine.2013.05.108. Review.

PMID:
24229717
9.

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S.

Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Review.

PMID:
23199963
10.

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.

Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA.

Vaccine. 2012 Nov 20;30 Suppl 5:F1-11. doi: 10.1016/j.vaccine.2012.05.090. Review.

PMID:
23199951
11.

Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.

Poljak M.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6. Review.

12.

Human papillomavirus vaccine introduction--the first five years.

Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM.

Vaccine. 2012 Nov 20;30 Suppl 5:F139-48. doi: 10.1016/j.vaccine.2012.05.039. Review. Erratum in: Vaccine. 2014 Feb 26;32(10):1225.

PMID:
23199957
13.

The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.

Vaccine. 2013 Dec 29;31 Suppl 5:F32-46. doi: 10.1016/j.vaccine.2012.07.092. Review.

14.

Barriers to human papillomavirus vaccine acceptability in Israel.

Fisher WA, Laniado H, Shoval H, Hakim M, Bornstein J.

Vaccine. 2013 Nov 22;31 Suppl 8:I53-7. doi: 10.1016/j.vaccine.2013.06.107. Review.

PMID:
24229720
15.

Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.

Sancho-Garnier H, Khazraji YC, Cherif MH, Mahnane A, Hsairi M, El Shalakamy A, Osgul N, Tuncer M, Jumaan AO, Seoud M.

Vaccine. 2013 Dec 30;31 Suppl 6:G51-7. doi: 10.1016/j.vaccine.2012.06.046. Review.

PMID:
24331820
16.

Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region.

Jumaan AO, Ghanem S, Taher J, Braikat M, Al Awaidy S, Dbaibo GS.

Vaccine. 2013 Dec 30;31 Suppl 6:G58-64. doi: 10.1016/j.vaccine.2012.06.097. Review.

PMID:
24331821
17.

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.

Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A.

Vaccine. 2010 Nov 29;28(51):8065-72. doi: 10.1016/j.vaccine.2010.10.017. Epub 2010 Nov 16. Review.

PMID:
20971114
18.

Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.

Vaccarella S, Bruni L, Seoud M.

Vaccine. 2013 Dec 30;31 Suppl 6:G32-44. doi: 10.1016/j.vaccine.2012.06.098. Review.

PMID:
24331818
19.

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?

Osazuwa-Peters N.

Vaccine. 2013 Nov 12;31(47):5500-5. doi: 10.1016/j.vaccine.2013.09.031. Epub 2013 Oct 3. Review.

PMID:
24095883
20.

Modeling preventative strategies against human papillomavirus-related disease in developed countries.

Canfell K, Chesson H, Kulasingam SL, Berkhof J, Diaz M, Kim JJ.

Vaccine. 2012 Nov 20;30 Suppl 5:F157-67. doi: 10.1016/j.vaccine.2012.06.091. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk